The evolving art of hematopoietic stem cell transplantation: Translational research in post-transplant immune reconstitution and immunosuppression

Research output: Contribution to journalArticle

9 Scopus citations


Allogeneic hematopoietic stem cell transplantation (SCT) offers the best chance for cure and/or long-term survival for a broad range of diseases, including many high-risk hematologic malignancies, bone marrow failure states and subsets of inherited metabolic diseases and hemoglobinopathies. Clinical advances in allogeneic SCT have resulted in dramatically improved clinical outcomes over the past two decades, resulting in a significant expansion of transplant utilization to many recipients who would previously have been excluded from consideration, including elderly recipients and individuals lacking matched sibling or unrelated donors. Despite these advances, significant clinical challenges remain, including delayed immune reconstitution and the frequent occurrence of acute and chronic graft-versus-host disease, especially in the unrelated donor transplant setting. Translational laboratory efforts, facilitated by technical advances in our ability to measure thymopoiesis and functional T cell subsets in humans, have resulted in an improved understanding of immune recovery and have provided novel insights that may lead to more rational and selective immunosuppression.

Original languageEnglish (US)
Pages (from-to)140-150
Number of pages11
JournalImmunologic Research
Issue number1-3
StatePublished - Dec 1 2013



  • Hematopoietic stem cell transplantation
  • Immune reconstitution
  • Immunosuppression
  • T cell immunology
  • Thymopoiesis

ASJC Scopus subject areas

  • Immunology

Cite this